Redhawk Wealth Advisors, Inc.
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1535811
MINNEAPOLIS, MN
Position in HALO
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,323,836
+$200,030 QoQ
Shares Held
29,690
-9.6% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#224
of 664 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Redhawk Wealth Advisors, Inc. holds $2,914,944 across 2 Biotechnology names. HALO ranks #1 (79.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
This page
|
29,690 | $2,323,836 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,190 | $591,108 |
All Filings in HALO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,323,836 | 29,690 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $2,123,806 | 32,861 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,423,944 | 36,017 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,682,410 | 36,575 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,946,536 | 37,419 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $2,079,695 | 32,592 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,818,453 | 38,035 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,104,600 | 36,768 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $1,864,696 | 35,613 | Shares | Sole | 2024-07-16 | |
| No filing history on record for this holder in this stock. | ||||||